共 50 条
- [35] Phase III Trial of Subcutaneous Epcoritamab plus R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S440 - S440
- [38] Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S216 - S216